These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 8581374

  • 1. Preparation of a bispecific F(ab')2 targeted to the human IL-2 receptor.
    Tso JY, Wang SL, Levin W, Hakimi J.
    J Hematother; 1995 Oct; 4(5):389-94. PubMed ID: 8581374
    [Abstract] [Full Text] [Related]

  • 2. Formation of a bispecific antibody by the use of leucine zippers.
    Kostelny SA, Cole MS, Tso JY.
    J Immunol; 1992 Mar 01; 148(5):1547-53. PubMed ID: 1531669
    [Abstract] [Full Text] [Related]

  • 3. Toward the production of bispecific antibody fragments for clinical applications.
    Carter P, Ridgway J, Zhu Z.
    J Hematother; 1995 Oct 01; 4(5):463-70. PubMed ID: 8581386
    [Abstract] [Full Text] [Related]

  • 4. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
    Rodrigues ML, Shalaby MR, Werther W, Presta L, Carter P.
    Int J Cancer Suppl; 1992 Oct 01; 7():45-50. PubMed ID: 1428403
    [Abstract] [Full Text] [Related]

  • 5. Transcription. Zen and the art of Fos and Jun.
    Kerppola T, Curran T.
    Nature; 1995 Jan 19; 373(6511):199-200. PubMed ID: 7816132
    [No Abstract] [Full Text] [Related]

  • 6. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
    Glennie MJ, McBride HM, Worth AT, Stevenson GT.
    J Immunol; 1987 Oct 01; 139(7):2367-75. PubMed ID: 2958547
    [Abstract] [Full Text] [Related]

  • 7. Engineering Fab' fragments for efficient F(ab)2 formation in Escherichia coli and for improved in vivo stability.
    Rodrigues ML, Snedecor B, Chen C, Wong WL, Garg S, Blank GS, Maneval D, Carter P.
    J Immunol; 1993 Dec 15; 151(12):6954-61. PubMed ID: 7903100
    [Abstract] [Full Text] [Related]

  • 8. Mechanism of specificity in the Fos-Jun oncoprotein heterodimer.
    O'Shea EK, Rutkowski R, Kim PS.
    Cell; 1992 Feb 21; 68(4):699-708. PubMed ID: 1739975
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. F(ab')2 molecules made from Escherichia coli produced Fab' with hinge sequences conferring increased serum survival in an animal model.
    Humphreys DP, Vetterlein OM, Chapman AP, King DJ, Antoniw P, Suitters AJ, Reeks DG, Parton TA, King LM, Smith BJ, Lang V, Stephens PE.
    J Immunol Methods; 1998 Aug 01; 217(1-2):1-10. PubMed ID: 9776570
    [Abstract] [Full Text] [Related]

  • 11. The designed protein M(II)-Gly-Lys-His-Fos(138-211) specifically cleaves the AP-1 binding site containing DNA.
    Harford C, Narindrasorasak S, Sarkar B.
    Biochemistry; 1996 Apr 09; 35(14):4271-8. PubMed ID: 8605175
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of action of a dominant-negative mutant of c-Jun.
    Brown PH, Chen TK, Birrer MJ.
    Oncogene; 1994 Mar 09; 9(3):791-9. PubMed ID: 8108121
    [Abstract] [Full Text] [Related]

  • 13. Experimental identification of homodimerizing B-ZIP families in Homo sapiens.
    Acharya A, Rishi V, Moll J, Vinson C.
    J Struct Biol; 2006 Aug 09; 155(2):130-9. PubMed ID: 16725346
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
    Ramirez-Carrozzi VR, Kerppola TK.
    J Mol Biol; 2001 Jan 19; 305(3):411-27. PubMed ID: 11152600
    [Abstract] [Full Text] [Related]

  • 17. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer.
    De Cesare D, Vallone D, Caracciolo A, Sassone-Corsi P, Nerlov C, Verde P.
    Oncogene; 1995 Jul 20; 11(2):365-76. PubMed ID: 7624151
    [Abstract] [Full Text] [Related]

  • 18. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M, Fogarasi M, Gruber H, Gresch O, Schäfer C, Aguib Y, Skerra A.
    Protein Eng Des Sel; 2009 Mar 20; 22(3):175-88. PubMed ID: 19022801
    [Abstract] [Full Text] [Related]

  • 19. An efficient screening assay for the rapid and precise determination of affinities between leucine zipper domains.
    Pernelle C, Clerc FF, Dureuil C, Bracco L, Tocque B.
    Biochemistry; 1993 Nov 02; 32(43):11682-7. PubMed ID: 8218236
    [Abstract] [Full Text] [Related]

  • 20. Thioether-bonded constructs of Fab'gamma and Fc gamma modules utilizing differential reduction of interchain disulfide bonds.
    Kan KS, Anderson VA, Leong WS, Smith AM, Worth AT, Stevenson GT.
    J Immunol; 2001 Jan 15; 166(2):1320-6. PubMed ID: 11145716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.